Dr. Steven M. Rotter, MD

Dr. Rotter practices at AmeriPath - Pompano Beach (SW 30th Ave) in Pompano Beach, Florida.

Dr. Rotter's NPI, 1528044229, was assigned on December 15, 2005. Dr. Rotter graduated from University of Maryland School of Medicine - Baltimore in 1986. Dr. Rotter holds Florida license ME104496.

Dr. Rotter's primary practice is AmeriPath - Pompano Beach (SW 30th Ave), at 895 Sw 30th Ave Ste 101, Pompano Beach, FL 33069. The practice phone is (954) 633-3770.

Dr. Rotter's primary practice is AmeriPath - Pompano Beach (SW 30th Ave) in Pompano Beach, Florida. The medical group on file is Exclusive Dermatology. Dmand AI also links Dr. Rotter to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rotter practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Rotter's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Rotter is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Rotter's licenses on file in 8 states: Florida, California, Missouri, New York, Virginia, District of Columbia, Maryland and Pennsylvania.

Dmand AI lists cancerous skin growth removal among the conditions Dr. Rotter treats.

CMS data shows 183 Medicare services from Dr. Rotter across 6 procedure codes in 2024, for 86 Medicare patients. Medicare paid $63,322 for them. Every service was in an office.

CMS counts 86 Medicare patients who saw Dr. Rotter in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rotter's median patient age at 70, with 45% women.

In 2024, Dr. Rotter wrote 71 Medicare Part D claims for 38 patients. 96% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $135 in total drug cost. In 2023, CMS named 50 claims across 2 drugs.

Dr. Rotter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 46 procedures of melanoma (skin cancer) excision by Dr. Rotter, more than 86% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Rotter. Dr. Rotter has published most often in J Dermatol Surg Oncol. Dr. Rotter's most frequent co-authors are Leonard Mark Dzubow, MD, Jonathan E. Efron, MD and Jeffrey Carl Pence, MD.

CMS Open Payments shows 74 general payments to Dr. Rotter from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 78% of the total. Kerecis Limited paid the most, $1,397.

Dmand AI lists 2 awards for Dr. Rotter.

Dr. Rotter graduated from University of Maryland School of Medicine - Baltimore in 1986. Dr. Rotter is a member of AAD and ASDS.

Dr. Rotter is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.